Significant Thursday Options Trading: MTSR, RYAM, FMC
Rayonier Advanced Materials Inc (RYAM) Options Activity: RYAM options have seen a volume of 9,871 contracts today, equating to about 987,100 underlying shares, which is 158.6% of its average daily trading volume over the past month. Notably, the $7 strike put option expiring on May 15, 2026, has had 4,251 contracts traded.
FMC Corp. Options Activity: FMC options have recorded a volume of 37,912 contracts today, representing approximately 3.8 million underlying shares, or 157.2% of its average daily trading volume. The $17.50 strike call option expiring on November 21, 2025, has seen 8,063 contracts traded.
Comparison of Trading Volumes: Both RYAM and FMC have experienced significantly high trading volumes today, indicating increased investor interest in their options.
Further Information: For more details on available expirations for MTSR, RYAM, or FMC options, StockOptionsChannel.com can be visited.
Get Free Real-Time Notifications for Any Stock
Analyst Views on RYAM
About RYAM
About the author

Multiple Material Stocks Receive 'F' EPS Revision Grades, Indicating Weak Earnings Momentum
- EPS Revision Grade Analysis: As the earnings season approaches, an analysis reveals that several mid to low cap material stocks have received an 'F' EPS revision grade, indicating significant downward pressure on future earnings expectations, which may lead to decreased investor confidence.
- List of Affected Companies: Companies such as American Battery Technology Company (ABAT), Algoma Steel Group Inc. (ASTL), and Eastman Chemical Company (EMN) have all received an 'F' grade, highlighting serious challenges in their earnings momentum.
- Market Impact Assessment: The poor EPS revision grades of these companies could adversely affect their stock performance, prompting investors to carefully assess associated risks, especially during the earnings season when market sensitivity to earnings is heightened.
- Industry Outlook: With the earnings season underway, the overall performance of the materials sector may be dragged down by these low-rated companies, leading investors to seek out better-performing firms within the industry for potential investment opportunities.

Altimmune Inc Receives FDA Breakthrough Therapy Designation for Pemvidutide, Shares Surge 23.6%
- FDA Certification Impact: Altimmune Inc's Pemvidutide received FDA Breakthrough Therapy Designation, leading to a 23.6% surge in shares to $4.34 on Monday, indicating strong market confidence in its potential efficacy and possibly accelerating its path to market.
- Clinical Progress: GH Research PLC's GH001 lifted from FDA clinical hold saw shares rise 33.8% to $17.72, reflecting significant advancements in drug development that are expected to enhance its competitive position in the market.
- Executive Change: Rayonier Advanced Materials Inc appointed Scott M. Sutton as the new CEO, resulting in a 14.1% increase in shares to $6.68, suggesting that this leadership change could bring new strategic directions and growth opportunities for the company.
- Market Rebound: The overall market showed strong performance with the S&P 500 index rising, reflecting investor optimism about economic recovery, which may drive more capital inflows into the stock market.









